Drugs.com: UC research explores factors tied to pregnancy rates in women on dialysis
UC nephrology researcher Dr. Silvi Shah examines racial and ethnic differences in pregnant women on dialysis
Pregnancy is not common in women on dialysis due to impaired fertility. A new study from UC finds that among patients with end-stage kidney disease (ESKD), there are racial disparities as to who is more likely to become pregnant. Native American, Hispanic and black women have a higher likelihood of pregnancy than white women.
The research, by Silvi Shah MD, which was featured in Drugs.com, shows for the first time that pregnancy rates in women with ESKD on dialysis are higher than in previous reports.
Dr. Silvi Shah in the CARE/Crawley Building
Shah's research was also published in MedicalXpress.com.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.